| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | -34.0% |
| Cost of Revenue | $1.7M | -44.9% |
| Gross Profit | $1.5M | -13.8% |
| R&D Expense | $2.3M | -49.1% |
| SG&A Expense | $10.5M | -24.0% |
| Operating Income | -$13.9M | +69.6% |
| Interest Expense | $135K | -92.2% |
| Pre-tax Income | -$10.3M | +75.5% |
| Income Tax | $41K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.0M | +2771.7% |
| Accounts Receivable | $276K | -49.8% |
| Current Assets | $113.8M | +2193.1% |
| Total Assets | $114.8M | +1606.0% |
| Current Liabilities | $6.5M | -60.9% |
| Total Liabilities | $7.6M | -58.2% |
| Stockholders' Equity | $107.2M | +1035.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.3M | +27.8% |
| Investing Cash Flow | $15.4M | +0.0% |
| Financing Cash Flow | $122.3M | +2359.1% |
| +41.4% |
| Net Income | -$10.3M | +80.5% |